Fig. 4From: Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The NetherlandsCost-effectiveness plane Key: The orange mark represents the base case ICER. The red mark represents the average ICER that was found in the PSA. ICER incremental cost-effectiveness ratio, PSA probabilistic sensitivity analysis, QALYs quality-adjusted life yearsBack to article page